Another week of White House chaos and American gun violence. Amid it all, we tried to parse what the Trump administration’s 2019 budget proposal meant for the biomedical and life-science worlds.
There was talk of tackling high drug prices in the... Read more »
Take a look at this blurb for a session about data privacy at the upcoming RSA conference on cybersecurity. It sounds a polite warning:
“The importance of privacy is often alluded to in generalized, value-laden terms that, while sincere, don’t necessarily... Read more »
In order to better position itself against competitors like Costco Wholesale (NASDAQ: COST) and Amazon (NASDAQ: AMZN), Sam’s Club, the bulk retailer owned by Walmart (NYSE: WMT), is now offering free shipping for many items as part of... Read more »
As the last year has shown, the tech industry has a significant problem with sexual harassment and ensuring that women are treated equitably in the workplace.
Now, some founders are seeking to use tech tools such as chatbots, artificial intelligence, analytics,... Read more »
The opioid crisis. Right to Try legislation. The first human trials of CRISPR-Cas9 gene editing technology. These are just a few of the many topics at the feet of the FDA this year.
Speaking at the BIO CEO & Investor Conference... Read more »
As president-elect, Donald Trump in January 2017 slammed drug companies for “getting away with murder” and said he supported Medicare negotiation. He vowed during last month’s State of the Union speech that drug prices “will come down.”
Today, his administration’s... Read more »
The black skirt had multiple personas. The fact that it was made of leather gave it an edgy vibe, but its A-line fit-and-flair cut was more flirty and feminine. “I fell in love with it,” says Michelle Bacharach, co-founder of FindMine.... Read more »
With multiple products on the market and many more coming, it’s easy to think that cancer immunotherapy has arrived. In reality, however, we’ve only just begun to figure out how to coax the immune system into killing cancer. That’s why a... Read more »
[Updated 2/12/2018, 1:37pm ET, see below.] With the opioid epidemic showing little sign of letting up, new ways of treating chronic pain are desperately needed. But the development of non-addictive, non-opioid pain drugs lags far behind drug R&D for... Read more »
The top biopharma story of the week involves the fast-moving field of lung cancer, which, as we’ve written previously, has several key trials reading out in 2018.
A big domino fell this week: data from a two-drug immunotherapy combination developed... Read more »
[Updated 2/8/18, 1:39 pm.] The race is on to sign up consumers seeking same-day delivery of groceries, household items, and personal goods.
Late on Wednesday, Amazon (NASDAQ: AMZN) announced it has started free two-hour delivery of products from... Read more »
Members of Congress are required to disclose many details about their personal finances.
Jared Polis, a Democratic U.S. Representative from Colorado—and a successful Internet entrepreneur—contends that elected representatives and certain staffers should also be required to disclose cryptocurrencies like Bitcoin... Read more »
Dozens of medical organizations and patient advocacy groups are pushing back against so-called “right-to-try” legislation that passed the Senate in August and is now under consideration in the House. An open letter sent today to House leaders is the latest opposition... Read more »